Biopharma Financial Market Recovery Has Legs As M&A Tally Climbs Higher

William Blair Finds Positive Signs In Q3

 
• By Mandy Jackson
  
Biopharma stock valuations are on the rise, prompting greater interest in IPOs and follow-on offerings (Shutterstock)

More from Scrip

More from Financing